Rhumbline Advisers »

Verve Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 81k 13.94
2023-09-30 $1.1M 80k 13.26
2023-06-30 $1.5M 79k 18.75
2023-03-31 $1.0M 72k 14.42
2022-12-31 $1.3M 68k 19.36
2022-09-30 $2.2M 64k 34.35
2022-06-30 $776k 51k 15.29
2022-03-31 $844k 37k 22.82
2021-12-31 $657k 18k 36.86
2021-09-30 $829k 18k 47.00